drugset / Trial / NCT05216055

Transverse Abdominus Plane Block Study

NCT05216055

Phase 2 Withdrawn University of Colorado, Denver
RandomizedParallel-groupSingle-blindSupportive care

Summary

Study the effect of laparoscopic guided TAP block on opioid consumption and associated costs using a mixture of dexmedetomidine, dexamethasone, and ropivacaine versus Liposomal bupivacaine (Exparel®) in patients who undergo elective minimally invasive colorectal surgery.

Timeline

Start
2022-04-19
Primary completion
2022-12-16
Completion
2022-12-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 266 mg
Subject Dexamethasone Small molecule 10 mg
Subject Dexmedetomidine Other / unclassified 50 ug
Subject Ropivacaine Other / unclassified 200 mg